EPAD paper reviews effects of disclosing AD biomarker results to healthy individuals
Current Alzheimer’s disease (AD) research initiatives focus on cognitively healthy individuals with biomarkers that are associated with the development of AD. It is unclear whether biomarker results should be returned…